Cargando…

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum

PURPOSE: Biomarkers used for predicting longitudinal cognitive change in Alzheimer’s disease (AD) continuum are still elusive. Tau pathology, neuroinflammation, and neurodegeneration are the leading candidate predictors. We aimed to determine these three aspects of biomarkers in cerebrospinal fluid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi-He, Lin, Rong-Rong, Huang, Hui-Feng, Xue, Yan-Yan, Tao, Qing-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280990/ https://www.ncbi.nlm.nih.gov/pubmed/35847667 http://dx.doi.org/10.3389/fnagi.2022.848180

Ejemplares similares

Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer’s continuum
por: Kuhn, Elizabeth, et al.
Publicado: (2021)

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
por: Streit, Wolfgang J., et al.
Publicado: (2009)

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
por: Lin, Rong-Rong, et al.
Publicado: (2021)

Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
por: Malpetti, Maura, et al.
Publicado: (2020)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
por: Wang, Qing, et al.
Publicado: (2022)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
por: Salvadó, Gemma, et al.
Publicado: (2022)

TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline
por: Wang, Chenfei, et al.
Publicado: (2022)

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
por: McCollum, Lauren E., et al.
Publicado: (2021)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K., et al.
Publicado: (2018)

Microglial pathology
por: Streit, Wolfgang J, et al.
Publicado: (2014)

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
por: Cicognola, Claudia, et al.
Publicado: (2018)

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
por: Trzeciakiewicz, Hanna, et al.
Publicado: (2020)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Tau as a Biomarker of Neurodegeneration
por: Holper, Sarah, et al.
Publicado: (2022)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
por: Dubbelman, Mark A., et al.
Publicado: (2020)

Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum?
por: Lassi, Michael, et al.
Publicado: (2023)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor
por: Maeda, Jun, et al.
Publicado: (2021)

Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
por: Seo, Eun Hyun, et al.
Publicado: (2021)

Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease
por: Yan, Yi‐Qun, et al.
Publicado: (2023)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum
por: Salvadó, Gemma, et al.
Publicado: (2021)

Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study
por: Wang, Yan-Li, et al.
Publicado: (2021)

Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum
por: Moody, Jason F., et al.
Publicado: (2022)

Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia
por: Vipin, Ashwati, et al.
Publicado: (2022)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
por: Lamontagne-Kam, Daniel, et al.
Publicado: (2023)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2018)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
por: Pérez, María J., et al.
Publicado: (2018)

Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
por: Španić, Ena, et al.
Publicado: (2019)

Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer’s Disease Continuum
por: Uchida, Yuto, et al.
Publicado: (2023)

Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
por: Drieu, Antoine, et al.
Publicado: (2023)

Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology
por: Wang, Hui-Fu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_68vihpqvcpgc0cvadac4varlqi